Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

Daniel L. Hertz, Karen Lisa Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman, Amanda L. Blackford, N. Lynn Henry, Kelley M. Kidwell, James M. Rae, Vered Stearns

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences